Cargando…

Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery disease

Asymmetric dimethylarginine (ADMA) is considered to be an atherogenic molecule. We aimed to investigate the relationship between ADMA and plaque vulnerability assessed by optical coherence tomography (OCT) in patients with stable coronary artery disease (CAD). Two hundred and forty-five patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shao-Sung, Huang, Wei-Chieh, Tsai, Chuan-Tsai, Chen, Ying-Ying, Lee, Sheng-Hua, Lu, Tse-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169809/ https://www.ncbi.nlm.nih.gov/pubmed/37160906 http://dx.doi.org/10.1038/s41598-023-32728-9

Ejemplares similares

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty
por: Derkacz, Arkadiusz, et al.
Publicado: (2011)

The levels of asymmetric dimethylarginine in patients with isolated coronary artery ectasia
por: Erden, Ismail
Publicado: (2010)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Plasma asymmetric dimethylarginine and L-arginine levels in Chinese patients with essential hypertension without coronary artery disease
por: Wang, Hongju, et al.
Publicado: (2011)

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study
por: Kruszelnicka, Olga, et al.
Publicado: (2016)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
por: Qian, Jing, et al.
Publicado: (2021)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease
por: Borgeraas, Heidi, et al.
Publicado: (2012)

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
por: Surdacki, Andrzej, et al.
Publicado: (2013)

Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis
por: Segarra, Gloria, et al.
Publicado: (2016)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)

Roles of Nitric Oxide and Asymmetric Dimethylarginine in Pregnancy and Fetal Programming
por: Huang, Li-Tung, et al.
Publicado: (2012)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X
por: Lu, Tse-Min, et al.
Publicado: (2017)

Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores
por: Tsai, Tsung-Ying, et al.
Publicado: (2022)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
por: Tan, Chaochao, et al.
Publicado: (2021)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
por: Kocayiğit, İbrahim, et al.
Publicado: (2020)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
por: Landim, M.B.P., et al.
Publicado: (2013)

Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
por: Kruszelnicka, Olga, et al.
Publicado: (2013)

Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD
por: Schou-Pedersen, Anne Marie Voigt, et al.
Publicado: (2018)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
por: SKRZYPCZYK, PIOTR, et al.
Publicado: (2020)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertension
por: Poręba, Rafał, et al.
Publicado: (2015)

The issue of plasma asymmetric dimethylarginine reference range – A systematic review and meta-analysis
por: Németh, Balázs, et al.
Publicado: (2017)

Restoration of Asymmetric Dimethylarginine–Nitric Oxide Balance to Prevent the Development of Hypertension
por: Tain, You-Lin, et al.
Publicado: (2014)

Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
por: Hsu, Chiao‐Po, et al.
Publicado: (2016)

The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients
por: Teng, Hsin-I, et al.
Publicado: (2022)

Increased Circulatory Asymmetric Dimethylarginine and Multiple Organ Failure: Bile Duct Ligation in Rat as a Model
por: Sheen, Jiunn-Ming, et al.
Publicado: (2014)

Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: A case–control study
por: Erre, Gian Luca, et al.
Publicado: (2016)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_amqhvk1s75p94tumn6fc7mlrkk